BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 18713462)

  • 21. High level of Sema3C is associated with glioma malignancy.
    Vaitkienė P; Skiriutė D; Steponaitis G; Skauminas K; Tamašauskas A; Kazlauskas A
    Diagn Pathol; 2015 Jun; 10():58. PubMed ID: 26032848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status.
    Roodakker KR; Elsir T; Edqvist PD; Hägerstrand D; Carlson J; Lysiak M; Henriksson R; Pontén F; Rosell J; Söderkvist P; Stupp R; Tchougounova E; Nistér M; Malmström A; Smits A
    Oncotarget; 2016 Nov; 7(45):72431-72442. PubMed ID: 27626492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.
    Yamamoto M; Mohanam S; Sawaya R; Fuller GN; Seiki M; Sato H; Gokaslan ZL; Liotta LA; Nicolson GL; Rao JS
    Cancer Res; 1996 Jan; 56(2):384-92. PubMed ID: 8542596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of cathepsin B and microvascular density increases with higher grade of astrocytomas.
    Wang M; Tang J; Liu S; Yoshida D; Teramoto A
    J Neurooncol; 2005 Jan; 71(1):3-7. PubMed ID: 15719267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical demonstration of the placental form of glutathione S-transferase, a detoxifying enzyme in human gliomas.
    Hara A; Yamada H; Sakai N; Hirayama H; Tanaka T; Mori H
    Cancer; 1990 Dec; 66(12):2563-8. PubMed ID: 2174303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clonal analysis of gliomas.
    Kattar MM; Kupsky WJ; Shimoyama RK; Vo TD; Olson MW; Bargar GR; Sarkar FH
    Hum Pathol; 1997 Oct; 28(10):1166-79. PubMed ID: 9343324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histone deacetylase inhibitors selectively suppress expression of HDAC7.
    Dokmanovic M; Perez G; Xu W; Ngo L; Clarke C; Parmigiani RB; Marks PA
    Mol Cancer Ther; 2007 Sep; 6(9):2525-34. PubMed ID: 17876049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterisation of molecular alterations in microdissected archival gliomas.
    Walker C; Joyce KA; Thompson-Hehir J; Davies MP; Gibbs FE; Halliwell N; Lloyd BH; Machell Y; Roebuck MM; Salisbury J; Sibson DR; Du Plessis D; Broome J; Rossi ML
    Acta Neuropathol; 2001 Apr; 101(4):321-33. PubMed ID: 11355303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction.
    van den Boom J; Wolter M; Kuick R; Misek DE; Youkilis AS; Wechsler DS; Sommer C; Reifenberger G; Hanash SM
    Am J Pathol; 2003 Sep; 163(3):1033-43. PubMed ID: 12937144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Receptor tyrosine kinase expression in astrocytic lesions: similar features in gliosis and glioma.
    Kristt DA; Reedy E; Yarden Y
    Neurosurgery; 1993 Jul; 33(1):106-15. PubMed ID: 7689190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aurora A is differentially expressed in gliomas, is associated with patient survival in glioblastoma and is a potential chemotherapeutic target in gliomas.
    Lehman NL; O'Donnell JP; Whiteley LJ; Stapp RT; Lehman TD; Roszka KM; Schultz LR; Williams CJ; Mikkelsen T; Brown SL; Ecsedy JA; Poisson LM
    Cell Cycle; 2012 Feb; 11(3):489-502. PubMed ID: 22274399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of COL6A1 as a differentially expressed gene in human astrocytomas.
    Fujita A; Sato JR; Festa F; Gomes LR; Oba-Shinjo SM; Marie SK; Ferreira CE; Sogayar MC
    Genet Mol Res; 2008 Apr; 7(2):371-8. PubMed ID: 18551403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors.
    Nakada M; Nakamura H; Ikeda E; Fujimoto N; Yamashita J; Sato H; Seiki M; Okada Y
    Am J Pathol; 1999 Feb; 154(2):417-28. PubMed ID: 10027400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NRF2, DJ1 and SNRX1 and their prognostic impact in astrocytic gliomas.
    Haapasalo J; Nordfors K; Granberg KJ; Kivioja T; Nykter M; Haapasalo H; Soini Y
    Histol Histopathol; 2018 Aug; 33(8):791-801. PubMed ID: 29441509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apparent diffusion coefficient in the evaluation of cerebral gliomas malignancy.
    Ignjatović J; Stojanov D; Zivković V; Ljubisavljević S; Stojanović N; Stefanović I; Benedeto-Stojanović D; Ignjatović N; Petrović S; Aracki-Trenkić A; Radovanović Z; Lazović L
    Vojnosanit Pregl; 2015 Oct; 72(10):870-5. PubMed ID: 26665552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Galectin-3 as an immunohistochemical tool to distinguish pilocytic astrocytomas from diffuse astrocytomas, and glioblastomas from anaplastic oligodendrogliomas.
    Neder L; Marie SK; Carlotti CG; Gabbai AA; Rosemberg S; Malheiros SM; Siqueira RP; Oba-Shinjo SM; Uno M; Aguiar PH; Miura F; Chammas R; Colli BO; Silva WA; Zago MA
    Brain Pathol; 2004 Oct; 14(4):399-405. PubMed ID: 15605987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Class I histone deacetylase expression in the human cyclic endometrium and endometrial adenocarcinomas.
    Krusche CA; Vloet AJ; Classen-Linke I; von Rango U; Beier HM; Alfer J
    Hum Reprod; 2007 Nov; 22(11):2956-66. PubMed ID: 17728353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and localization of 92 kDa type IV collagenase/gelatinase B (MMP-9) in human gliomas.
    Rao JS; Yamamoto M; Mohaman S; Gokaslan ZL; Fuller GN; Stetler-Stevenson WG; Rao VH; Liotta LA; Nicolson GL; Sawaya RE
    Clin Exp Metastasis; 1996 Jan; 14(1):12-8. PubMed ID: 8521611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of interleukin-1beta mRNA and protein in human gliomas assessed by RT-PCR and immunohistochemistry.
    Sasaki A; Tamura M; Hasegawa M; Ishiuchi S; Hirato J; Nakazato Y
    J Neuropathol Exp Neurol; 1998 Jul; 57(7):653-63. PubMed ID: 9690669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA hypermethylation and histone modifications downregulate the candidate tumor suppressor gene RRP22 on 22q12 in human gliomas.
    Schmidt N; Windmann S; Reifenberger G; Riemenschneider MJ
    Brain Pathol; 2012 Jan; 22(1):17-25. PubMed ID: 21631628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.